Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Observational Study to Evaluate Patient-reported Outcome and Physical Activity Using Smartphone-based Application and Wearable Device in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

NCT04736576 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04736576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04736576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Observational Study to Evaluate Patient-reported Outcome and Physical Activity Using Smartphone-based Application and Wearable Device in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy
Lead sponsor
Pfizer
Phase
Not applicable
Overall status
Completed
Start date
February 24, 2021
Completion date
March 24, 2023
Enrollment
99 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer